The Transcription Profile Unveils the Cardioprotective Effect of Aspalathin against Lipid Toxicity in an in Vitro H9c2 Model

Molecules

Volumn 22, Issue 2, 2017, Pages

  Johnson, Rabia ^a,b   Dludla, Phiwayinkosi V ^a,b   Muller, Christo J F ^a,b,c   Huisamen, Barbara ^a,b   Essop, M Faadiel ^d   Louw, Johan ^a,c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c UNIVERSITY OF ZULULAND   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Aspalathin; Cardiomyopathy; Diabetes mellitus; Hyperglycemia; Lipotoxicity; Polyphenols

Indexed keywords

ASPALATHIN; CARDIOTONIC AGENT; CHALCONE DERIVATIVE; CYTOKINE; FATTY ACID; LEPTIN; LIPID; PLANT EXTRACT; TRANSCRIPTOME;

ANIMAL; APOPTOSIS; CARDIAC MUSCLE CELL; CELL LINE; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID METABOLISM; MALE; METABOLISM; MOUSE; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; CELL LINE; CHALCONES; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INSULIN RESISTANCE; LEPTIN; LIPID METABOLISM; LIPIDS; MALE; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; PLANT EXTRACTS; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 85014050634     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22020219     Document Type: Article

References (56)

1. Gollucke, A. P.; Peres, R. C.; Odair, A. J.; Ribeiro, D. A. Polyphenols: A nutraceutical approach against diseases. Recent Pat. Food Nutr. Agric. 2013, 5, 214-219.
2. Bahadoran, Z.; Mirmiran, P.; Azizi, F. Dietary polyphenols as potential nutraceuticals in management of diabetes: A review. J. Diabetes Metab. Disord. 2013, 12, 43.
3. Pantsi, W. G.; Marnewick, J. L.; Esterhuyse, A. J.; Rautenbach, F.; van Rooyen, J. Rooibos (Aspalathus linearis) offers cardiac protection against ischaemia/reperfusion in the isolated perfused rat heart. Phytomedicine 2011, 18, 1220-1228.
4. Ulicná, O.; Vancová, O.; Bozek, P.; Cársky, J.; Sebeková, K.; Boor, P.; Nakano, M.; Greksák, M. Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats. Physiol. Res. 2006, 55, 157-164.
5. Marnewick, J. L.; Rautenbach, F.; Venter, I.; Neethling, H.; Blackhurst, D. M.; Wolmarans, P.; Macharia M. Effects of rooibos (Aspalathus linearis) on oxidative stress and biochemical parameters in adults at risk for cardiovascular disease. J. Ethnopharmacol. 2011, 133, 46-52.
6. Mazibuko, S. E.; Joubert, E.; Johnson, R.; Louw, J.; Opoku, A. R.; Muller, C. J. F. Aspalathin improves glucose and lipid metabolism in 3T3-L1 adipocytes exposed to palmitate. Mol. Nutr. Food Res. 2015, 59, 2199-2208.
7. Muller, C. J. F.; Joubert, E.; De Beer, D.; Sanderson, M.; Malherbe, C. J.; Fey, S. J.; Louw, J. Acute assessment of an aspalathin-enriched green rooibos (Aspalathus linearis) extract with hypoglycemic potential. Phytomedicine 2012, 20, 32-39.
8. Kawano, A.; Nakamura, H.; Hata, S.; Minakawa, M.; Miura, Y.; Yagasaki, K. Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice. Phytomedicine 2009, 16, 437-443.
9. Dludla, P. V.; Muller, C. J. F.; Louw, J.; Joubert, E.; Salie, R.; Opoku, A. R.; Johnson, R. The cardioprotective effect of an aqueous extract of fermented rooibos (Aspalathus linearis) on cultured cardiomyocytes derived from diabetic rats. Phytomedicine 2014, 21, 595-601.
10. Johnson, R.; Dludla, P.; Joubert, E.; February, F.; Mazibuko, S.; Ghoor, S.; Muller C.; Louw, J. Aspalathin, a dihydrochalcone C-glucoside, protects H9c2 cardiomyocytes against high glucose-induced shifts in substrate preference and apoptosis. Mol. Nutr. Food Res. 2016, 60, 922-934.
11. Smit, S. E. An Investigation into the Effects of Aspalathin on Myocardial Glucose Transport Using Cardiomyocytes from Control and Obesity-Induced Insulin Resistant Rats, Terminally Differentiated H9c2 Cells. Master Thesis, Stellenbosch University, Stellenbosch, South Africa, March 2016. Available online: http://scholar. sun. ac. za/handle/10019. 1/98490 (accessed on 1 November 2016).
12. Sharma, S.; Adrogue, J. V.; Golfman, L.; Uray, I.; Lemm, J.; Youker, K.; Noon, G. P.; Frazier, O. H.; Taegtmeyer, H. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004, 18, 1692-1700.
13. Silver, D. L.; Jiang, X. C.; Tall, A. R. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J. Biol. Chem. 1999, 274, 4140-4146.
14. Goldberg, I. J.; Trent, C. M.; Schulze, P. C. Lipid metabolism and toxicity in the heart. Cell Metab. 2012, 15, 805-812.
15. Marfella, R.; Di Filippo, C.; Portoghese, M.; Barbieri, M.; Ferraraccio, F.; Siniscalchi, M.; Cacciapuoti, F.; Rossi, F.; D'Amico, M.; Paolisso, G. Myocardial lipid accumulation in patients with pressure-overload heart and metabolic syndrome. J. Lipid Res. 2009, 50, 2314-2323.
16. Son, N. H.; Park, T. S.; Yamashita, H.; Yokoyama, M.; Huggins, L. A.; Okajima, K.; Homma, S.; Szabolcs, M. J.; Huang, L. S.; Goldberg, I. J. Cardiomyocytes expression of PPAR leads to cardiac dysfunction in mice. J. Clin. Investig. 2007, 117, 2791-2801.
17. Rajapurohitam, V.; Gan, X. T.; Kirshenbaum, L. A.; Karmazyn, M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ. Res. 2003, 93, 277-279.
18. Jonassen, A. K.; Sack, M. N.; Mjøs, O. D.; Yellon, D. M. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ. Res. 2001, 89, 1191-1198.
19. Paolisso, G.; Manzella, D.; Montano, N.; Gambardella, A.; Varricchio, M. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J. Clin. Endocrinol. Metab. 1999, 85, 1810-1814.
20. Drosatos, K.; Khan, R. S.; Trent, C. M.; Jiang, H.; Son, N.; Blaner, W. S.; Homma, S.; Schulze, P. C.; Goldberg, I. J. PPAR activation prevents sepsis-related cardiac dysfunction and mortality in mice. Circ. Heart Fail. 2013, 6, 550-562.
21. Dludla, P. V.; Muller, C. J. F.; Joubert, E.; Louw, J.; Gabuza, K. B.; Huisamen, B.; Essop, M. F.; Johnson, R. Phenylpyruvic acid-2-O-D-glucoside attenuates high glucose-induced apoptosis in H9c2 cardiomyocytes. Planta Med. 2016, 82, 1468-1474.
22. Marfella, R.; Portoghese, M.; Ferraraccio, F.; Siniscalchi, M.; Babieri, M.; Di Filippo, C.; D'Amico, M.; Rossi, F.; Paolisso, G. Thiazolidinediones may contribute to the intramyocardial lipid accumulation in diabetic myocardium: Effects on cardiac function. Heart 2009, 95, 1020-1022.
23. Tamang, H. K.; Timilsina, U.; Singh, K. P.; Shrestha, S.; Raman, R. K.; Panta, P.; Karna, P.; Khadka, L.; Dahal C. Apo B/Apo A-I ratio is statistically a better predictor of cardiovascular disease (CVD) than conventional lipid profile: A study from Kathmandu valley, Nepal. J. Clin. Diagn. Res. 2014, 8, 34-36.
24. DeFronzo, R. A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: The missing links. The Claude Bernard Lecture 2009. Diabetologia 2010, 53, 1270-1287.
25. Chan, D. C.; Watts, G. F. Apolipoproteins as markers and managers of coronary risk. QJM 2006, 99, 277-287.
26. Haim, Y.; Blüher, M.; Slutsky, N.; Goldstein, N.; Klöting, N.; Harman-Boehm, I.; Kirshtein, B.; Ginsberg, D.; Gericke, M.; Guiu Jurado, E.; et al. Elevated autophagy gene expression in adipose tissue of obese humans: A potential non-cell-cycle-dependent function of E2F1. Autophagy 2015, 11, 2074-2088.
27. Sundell, J.; Huupponen, R.; Raitakari, O. T.; Nuutila, P.; Knuuti, J. High serum leptin is associated with attenuated coronary vasoreactivity. Obes. Res. 2003, 11, 776-782.
28. Zdychová, J.; Komers, R. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol. Res. 2005, 54, 1-16.
29. Bockus, L. B.; Humphries, K. M. cAMP-dependent protein kinase (PKA) signaling is impaired in the diabetic heart. J. Biol. Chem. 2015, 290, 29250-29258.
30. Weber, H. E.; Menahan, L. A.; Chaudhuri, S. N.; Shipp, J. C. Effect of experimental diabetes and glucagon on cAMP-dependent protein kinase in rat liver. Diabetologia 1977, 13, 153-157.
31. Beca, S.; Ahmad, F.; Shen, W.; Liu, J.; Makary, S.; Polidovitch, N.; Sun, J.; Hockman, S.; Chung, Y. W.; Movsesian, M.; et al. PDE3A regulates basal myocardial contractility through Interacting with SERCA2asignaling complexes in mouse heart. Circ. Res. 2013, 112, 289-297.
32. Hoerter, J.; Gonzalez-Barroso, M. D.; Couplan, E.; Mateo, P.; Gelly, C.; Cassard-Doulcier, A. M.; Diolez, P.; Bouillaud, F. Mitochondrial uncoupling protein 1 expressed in the heart of transgenic mice protects against ischemic-reperfusion damage. Circulation 2004, 110, 528-533.
33. Vettor, R.; Fabris, R.; Serra, R.; Lombardi, A. M.; Tonello, C.; Granzotto, M.; Marzolo, M. O.; Carruba, M. O.; Ricquier, D.; Federspil, G.; et al. Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle. Int. J. Obes. Relat. Metab. Disord. 2002, 26, 838-847.
34. Barreto, P.; Okura, V. K.; Neshich, I. A.; Maia Ide, G.; Arruda, P. Overexpression of UCP1 in tobacco induces mitochondrial biogenesis and amplifies a broad stress response. BMC Plant Biol. 2014, 14, 144.
35. Zoidis, E.; Ghirlanda-Keller, C.; Schmid, C. Stimulation of glucose transport in osteoblastic cells by parathyroid hormone and insulin-like growth factor I. Mol. Cell Biochem. 2011, 348, 33-42.
36. Kajstura, J.; Fiordaliso, F.; Andreoli, A. M.; Li, B.; Chimenti, S.; Medow, M. S.; Limana, F.; Nadal-Ginard, B.; Leri, A.; Anversa, P. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001, 50, 1414-1424.
37. Lacana, E.; D'Adamio, L. Regulation of Fas ligand expression and cell death by apoptosis-linked gene 4. Nat. Med. 1999, 5, 542-547.
38. Xue, W.; Cai, L.; Tan, Y.; Thistlethwaite, P.; Kang, Y. J.; Li, X.; Feng, W. Cardiac-specific overexpression of HIF-1 prevents deterioration of glycolytic pathway and cardiac remodeling in streptozotocin-induced diabetic mice. Am. J. Pathol. 2010, 177, 97-105.
39. Natarajan, R.; Bai, W.; Lanting, L.; Gonzales, N.; Nadler, J. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am. J. Physiol. 1997, 273, H2224-H2231.
40. Xu, Z.; Castellino, F. J.; Ploplis, V. A. Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture. Blood 2010, 115, 2038-2047.
41. Arabacilar, P.; Marber, M. The case for inhibiting p38 mitogen-activated protein kinase in heart failure. Front. Pharmacol. 2015, 6, 102.
42. Hoshino, A.; Mita, Y.; Okawa, Y.; Ariyoshi, M.; Iwai-Kanai, E.; Ueyama, T.; Ikeda, K.; Ogata, T.; Matoba, S. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat. Commun. 2013, 4, 2308.
43. Roy, M.; Kageyama, Y.; Iijima, M.; Sesaki, H. PARK2/Parkin becomes critical when DNM1L/Drp1 is absent. Autophagy 2015, 119, 573-574.
44. Wende, A. R.; Symons, J. D.; Abel, E. D. Mechanisms of lipotoxicity in the cardiovascular system. Curr. Hypertens. Rep. 2012, 149, 517-531.
45. Xu, F. P.; Chen, M. S.; Wang, Y. Z.; Yi, Q.; Lin, S. B.; Chen, A. F.; Luo, J. D. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004, 110, 1269-1275.
46. Yang, R.; Barouch, L. A. Leptin signaling and obesity: Cardiovascular consequences. Circ. Res. 2007, 101, 545-559.
47. Cuff, C. A.; Kothapalli, D.; Azonobi, I.; Chun, S.; Zhang, Y.; Belkin, R.; Yeh, C.; Secreto, A.; Assoian, R. K.; Rader, D. J.; et al. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Investig. 2001, 108, 1031-1040.
48. Dong, Z. M.; Chapman, S. M.; Brown, A. A.; Frenette, P. S.; Hynes, R. O.; Wagner, D. D. The combined role of P-and E-Selectins in atherosclerosis. J. Clin. Investig. 1998, 102, 145-152.
49. Tamiya, T.; Kashiwagi, I.; Takahashi, R.; Yasukawa, H.; Yoshimura, A. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: Regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 980-985.
50. Duvezin-Caubet, S.; Jagasia, R.; Wagener, J.; Hofmann, S.; Trifunovic, A.; Hansson, A.; Chomyn, A.; Bauer, M. F.; Attardi, G.; Larsson, N. G.; et al. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J. Biol. Chem. 2006, 281, 37972-37979.
51. Chen, S. C.; Kochan, J. P.; Campfield, L. A.; Burn, P.; Smeyne, R. J. Splice variants of the OB receptor gene are differentially expressed in brain and peripheral tissues of mice. J. Recept. Signal Transduct. Res. 1999, 19, 245-266.
52. Han, Z.; Achilonu, M. C.; Kendrekar, P. S.; Joubert, E.; Ferreira, D.; Bonnet, S. L.; van der Westhuizen, J. H. Concise and scalable synthesis of aspalathin, a powerful plasma sugar-lowering natural product. J. Nat. Prod. 2014, 77, 583-588.
53. Matthews, D. R.; Hosker, J. P.; Rudenski, A. S.; Naylor, B. A.; Treacher, D. F.; Turner, R. C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412-419.
54. Karagiannis, T. C.; Lin, A. J.; Ververis, K.; Chang, L.; Tang, M. M.; Okabe, J.; El-Osta, A. Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. Aging 2010, 2, 659-668.
55. Jensen, L. J.; Kuhn, M.; Stark, M.; Chaffron, S.; Creevey, C.; Muller, J.; Doerks, T.; Julien, P.; Roth, A.; Simonovic, M.; et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009, 37, D412-D416.
56. Szklarczyk, D.; Franceschini, A.; Wyder, S.; Forslund, K.; Heller, D.; Huerta-Cepas, J.; Simonovic, M.; Roth, A.; Santos, A.; Tsafou, K. P.; et al. STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015, 43, D447-D452.